Australia needs higher standards of dying
A new PC report says people must die where and how they want to, not where the health system says they must
Ex-Lendlease exec Michael Eggington to lead ThirdAge
Former top Lendlease retirement executive Michael Eggington has joined boutique residential developer Thirdi to lead the company's first foray into retirement living development, ThirdAge.
Immune system's secret weapon discovered
Australian scientists have discovered that group of immune cells, once considered junk, are actually a secret weapon the body uses to fight disease.
Private equity lines up for Kiwi radiology business
The shiraz is flowing at Allier Capital, but it's not what you think it is.
New strategies to beat mid-life doldrums
New approaches in business and the community are helping people to overcome the so-called midlife "crisis".
Blackmores last one standing in China frenzy
JP Morgan expects Blackmores shares to head to $150 by year's end. It is now the last big independent Australian vitamins firm.
Nature's Care to go upmarket in China
Australia's No. 3 vitamins player, Nature's Care, has followed Swisse and Vitaco in being swallowed by Chinese buyers.
AuMake aims to build rival to Blackmores
The 50,000 daigous in Australia want to make a decent profit margin which opens the way for new vitamins products.
Ageing Thailand in developers' sights
Thailand's ageing population and retirement appeal for foreigners is fueling opportunities for property developers.
R&D caps will shrink us, biotechs warn
Any capping of the R&D; refund available to life sciences start-ups would threaten Australia's booming industry in conducting clinical trials...
